Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0942820090080020131
Journal of Korean Brain Tumor Society
2009 Volume.8 No. 2 p.131 ~ p.137
Clinical Analysis of Treatment in the Intracranial Hemangioblastomas
Kim Ho-Sang

Cho Won-Ho
Hur Byeong-Ik
Kang Dong-Wan
Cha Seung-Heon
Choi Chang-Hwa
Abstract
Objective: Intracranial hemangioblastomas are benign vascular tumors arising either sporadically or as a manifestation of von Hippel-Lindau(VHL) disease. We analysed a series of patients with intracranial hemangioblastoma to review our strategy of treatment.

Materials and Methods: Consecutive patients with intracranial hemangioblastoma who underwent surgery and then adjuvant therapy if needs, at our institute. Eighteen patients(14 female and 4 male patients) underwent 21 operations for removal of 19 intracranial hemangioblastoma(age at surgery 45¡¾9.2 years, follow-up duration 37¡¾8 months). Serial clinical examinations, imaging studies, and operative records were analyzed.

Results: Twelve patients(66%) had sporadic hemangioblastomas. And six patients(34%) were von Hippel-Lindau disease. Symptoms and signs included headache(64.7%), dizziness(64.7%), gait disturbance(20%), and hydrocephalus(56%). Total resection rate was 71%(15/21). Six patients whose tumor were partially removed. Adjuvant radiosurgery was performed to 6 patients. Four patients of them were stabilized after radiosurgery. Two cystic hemangioblastoma cases were aggravated in the size of cystic portion, so revision were performed. Preoperative tumor embolization was performed in 2 cases. One VHL patient was expired due to pheochromocytoma.

Conclusion: Symptoms and signs caused by intracranial hemangioblastoma can be treated safely and effectively with surgical resection. Radiosurgery may be adequate adjuvant therapy for remnant intracranial hemangioblastoma except cystic hemangioblastomas.
KEYWORD
Hemangioblastoma, Radiosurgery, Gamma knife
FullTexts / Linksout information
Listed journal information
´ëÇÑÀÇÇÐȸ ȸ¿ø